Superworth

TransMedics EV/EBIT TMDX

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2024.

Today, Nov 2, 2026
32.9×
2-year median
49.3×
Against its 2-year history
16th
percentile: 0 is its lowest day, 100 its highest
2-year range
27.2× to 98.5×
Peer median
21.8×

TransMedics' EV/EBIT is 32.9× as of Nov 2, 2026.

That is below its 2-year median of 49.3×, lower than on 84% of days in the last 2 years.

Over that time it ranged from 27.2× in May 2026 to 98.5× in Nov 2024.

The median for 4 medical device stocks of a similar size is 21.8×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far32.9×27.2×51.6×
202544.8×41.5×96.0×
202471.1×71.1×98.5×

Against its peers

Companies in Medical - Devices nearest TransMedics' size, closest first, today.

CompanyEV/EBIT
TMDXTransMedics32.9×
CNMDCONMED19.8×
ITGRInteger29.7×
LIVNLivaNova22.4×
ZBHZimmer Biomet21.3×
Peer median21.8×

Where TransMedics ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on TransMedics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.